Related references
Note: Only part of the references are listed.Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
Bryan Frey et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Monitoring -synuclein multimerization in vivo
Vibha Prasad et al.
FASEB JOURNAL (2019)
In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species
Martin Kiechle et al.
CELL REPORTS (2019)
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
N. N. Vaikath et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
Waijiao Cai et al.
EBIOMEDICINE (2018)
Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated -Synuclein-selective Autophagic Degradation
Manel Dahmene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity
Anna Villar-Pique et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Phosphorylation induces distinct alpha-synuclein strain formation
Meng-Rong Ma et al.
SCIENTIFIC REPORTS (2016)
Dimerization propensities of Synucleins are not predictive for Synuclein aggregation
Katrin Eckermann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain
Rosalind F. Roberts et al.
BRAIN (2015)
Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies
Simon Moussaud et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
Ulf Dettmer et al.
NATURE COMMUNICATIONS (2015)
Efficient Modification of Alpha-Synuclein Serine 129 by Protein Kinase CK1 Requires Phosphorylation of Tyrosine 125 as a Priming Event
Jonas Kosten et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Charting the molecular links between driver and susceptibility genes in colorectal cancer
Rodrigo Arroyo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Correction: Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLoS One (2014)
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana F. Lazaro et al.
PLOS GENETICS (2014)
The CK1 family: contribution to cellular stress response and its role in carcinogenesis
Uwe Knippschild et al.
FRONTIERS IN ONCOLOGY (2014)
Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization
Alireza Roostaee et al.
MOLECULAR NEURODEGENERATION (2013)
Screening for differentially expressed genes between left- and right-sided colon carcinoma by microarray analysis
Hong Zhu et al.
ONCOLOGY LETTERS (2013)
Direct detection of alpha synuclein oligomers in vivo
Hemi Dimant et al.
Acta Neuropathologica Communications (2013)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease
Jinxia Zhou et al.
ACTA NEUROPATHOLOGICA (2011)
Improved Immunodetection of Endogenous α-Synuclein
Byung Rho Lee et al.
PLOS ONE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice
Kunikazu Tanji et al.
ACTA NEUROPATHOLOGICA (2010)
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Martial K. Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo
Justin Legleiter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
Katerina E. Paleologou et al.
BRAIN (2009)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis
Kai-Yin Chau et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Lewy Body Pathology in Normal Elderly Subjects
William R. Markesbery et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein
Katerina E. Paleologou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Accumulation and clearance of α-synuclein aggregates demonstrated by time-lapse imaging
Felipe Opazo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions
Melinda A. McFarland et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Dysbindin structural homologue CK1BP is an isoform-selective binding partner of human casein kinase-1
HS Yin et al.
BIOCHEMISTRY (2006)
Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies
J Klucken et al.
ACTA NEUROPATHOLOGICA (2006)
The human orthologue of a novel apoptosis response gene induced during rat myelomonocytic stem cell apoptosis maps to 20q13.12
T Lucas et al.
STEM CELLS AND DEVELOPMENT (2005)
Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules
GB Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Ubiquitination of α-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function
GK Tofaris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
R Sharon et al.
NEURON (2003)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
Visualization of interactions among bZip and Rel family proteins in living cells using bimolecular fluorescence complementation
CD Hu et al.
MOLECULAR CELL (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain
K Yasojima et al.
BRAIN RESEARCH (2000)
Share Paper
